Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-23-071284
Filing Date
2023-08-28
Accepted
2023-08-28 16:57:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea184325-13gpurchase_eterna.htm SC 13G 56941
  Complete submission text file 0001213900-23-071284.txt   58739
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Subject) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42217 | Film No.: 231216906
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1395 BRICKELL AVENUE, SUITE 800 MIAMI FL 33131
Business Address 1395 BRICKELL AVENUE, SUITE 800 MIAMI FL 33131 305-697-9610
Purchase Capital LLC (Filed by) CIK: 0001990418 (see all company filings)

EIN.: 204960791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G